Pharmaceutical CFO Joins Cancer-Fighting Biotechnology Company

143

Biren Amin ’00 joins Pyramid Biosciences as its chief financial and strategy officer, where he will oversee the advancement and expansion of Pyramid’s company pipeline. Mr. Amin previously served as chief financial officer of Immuneering Corporation and spent two decades on Wall Street performing equity research covering biotechnology and pharmaceutical companies.